Mid- Hudson Medical Group P C

Mid- Hudson Medical Group P C was paid $3.26M by Medicaid between Jan 2018 and Nov 2021, across 52 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 17% of everything it billed.

Compared with peers

Next to other General Practice Physician providers in New York

Rank by total paid#13 of 178

Median peer was paid$27K

This provider vs. median121×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	7,226	$438K
2019	10,072	$584K
2020	15,779	$1.12M
2021	18,573	$1.12M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	17%	5,149	4,818	$568K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	16%	4,655	4,560	$508K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	13%	8,450	8,350	$420K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	13%	8,444	8,344	$420K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	8.0%	5,239	5,232	$261K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	6.8%	1,554	1,505	$223K
88174		5.8%	5,620	5,612	$190K
88305	Level IV - Surgical pathology, gross and microscopic examination	3.6%	569	566	$118K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	2.9%	2,911	2,767	$96K
99203	Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity	2.4%	507	507	$79K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	2.0%	1,513	1,470	$64K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	1.7%	1,502	1,500	$56K

40 more codes

87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	1.2%	648	$38K
99214	Doctor's office visit, returning patient (more involved)	<1%	187	$29K
88141		<1%	467	$21K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	228	$18K
87631		<1%	100	$18K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	87	$17K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	135	$16K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	119	$12K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	86	$11K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	70	$11K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	18	$7K
77063	Screening digital breast tomosynthesis, bilateral	<1%	86	$7K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	604	$7K
88142		<1%	242	$6K
87625		<1%	111	$6K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	38	$6K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	94	$4K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	25	$4K
76641		<1%	14	$3K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	259	$3K
81513		<1%	453	$2K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	12	$2K
92551		<1%	168	$2K
87529		<1%	12	$1K
80053	Comprehensive metabolic panel	<1%	56	$772.20
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	66	$330.00
82728		<1%	14	$253.82
83550		<1%	14	$162.68
90472	Immunization administration, each additional vaccine (list separately)	<1%	13	$90.00
90686		<1%	216	$40.06
90734		0%	12	$0.00
99051		0%	64	$0.00
99173		0%	144	$0.00
90670		0%	29	$0.00
99000		0%	293	$0.00
36415	Collection of venous blood by venipuncture	0%	290	$0.00
90723		0%	27	$0.00
90696		0%	12	$0.00
90647		0%	12	$0.00
90680		0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGARVEY, JOSEPH (CEO, PRESIDENT & CHAIRMAN OF THE BD)